Literature DB >> 29260342

Predictors for a further local in-brain progression after re-craniotomy of locally recurrent cerebral metastases.

Marcel A Kamp1, Igor Fischer2, Maxine Dibué-Adjei3, Christopher Munoz-Bendix3, Jan-Frederick Cornelius3, Hans-Jakob Steiger3, Philipp J Slotty3, Bernd Turowski4, Marion Rapp3, Michael Sabel3.   

Abstract

Treatment of recurrent cerebral metastases is an emerging challenge due to the high local failure rate after surgery or radiosurgery and the improved prognosis of patients with malignancies. A total of 36 patients with 37 metastases who underwent surgery for a local in-brain progression of a cerebral metastasis after previous metastasectomy were retrospectively analyzed. Degree of surgical resection on an early postoperative MRI within 72 h after surgery was correlated with the local in-brain progression rate and overall survival. Complete surgical resection of locally recurrent cerebral metastases as confirmed by early postoperative MRI could only be achieved in 37.8%. Detection of residual tumor tissue on an early MRI following recurrent metastasis surgery correlated with further local in-brain progression when defining a significance level of p = 0.05 but not after Šidák or Bonferroni significance level correction for multiple testing: However, definite local tumor control could finally be achieved in 91.9% after adjuvant therapy. Overall survival after recurrent metastasectomy was significantly higher as predicted by diagnosis-specific graded prognostic assessment (12.9 ± 2.3 vs. 8.4 ± 0.7 months; p < 0.0001). However, our series involved a limited number of heterogeneous patients. A larger, prospective, and controlled study is required. Considering the adequate local tumor control achieved in the vast majority of patients, surgery of recurrent metastases may represent one option in a multi-modal treatment approach of patients suffering from locally recurrent cerebral metastases.

Entities:  

Keywords:  Metastasis; Postoperative MRI; Recurrence; Recurrent metastasis; Resection; Surgery

Mesh:

Year:  2017        PMID: 29260342     DOI: 10.1007/s10143-017-0931-z

Source DB:  PubMed          Journal:  Neurosurg Rev        ISSN: 0344-5607            Impact factor:   3.042


  43 in total

Review 1.  Brain tumors.

Authors:  L M DeAngelis
Journal:  N Engl J Med       Date:  2001-01-11       Impact factor: 91.245

Review 2.  Resecting diffuse low-grade gliomas to the boundaries of brain functions: a new concept in surgical neuro-oncology.

Authors:  H Duffau
Journal:  J Neurosurg Sci       Date:  2015-04-24       Impact factor: 2.279

3.  Radiation injury vs. recurrent brain metastasis: combining textural feature radiomics analysis and standard parameters may increase 18F-FET PET accuracy without dynamic scans.

Authors:  Philipp Lohmann; Gabriele Stoffels; Garry Ceccon; Marion Rapp; Michael Sabel; Christian P Filss; Marcel A Kamp; Carina Stegmayr; Bernd Neumaier; Nadim J Shah; Karl-Josef Langen; Norbert Galldiks
Journal:  Eur Radiol       Date:  2016-11-16       Impact factor: 5.315

4.  The treatment of patients with recurrent brain metastases. A retrospective analysis of 109 patients with nonsmall cell lung cancer.

Authors:  E Arbit; M Wroński; M Burt; J H Galicich
Journal:  Cancer       Date:  1995-09-01       Impact factor: 6.860

Review 5.  Management of brain metastases: the indispensable role of surgery.

Authors:  George Al-Shamy; Raymond Sawaya
Journal:  J Neurooncol       Date:  2009-04-09       Impact factor: 4.130

6.  Clinical outcomes of patients treated with a second course of stereotactic radiosurgery for locally or regionally recurrent brain metastases after prior stereotactic radiosurgery.

Authors:  Daniel H Kim; Timothy E Schultheiss; Eric H Radany; Behnam Badie; Richard D Pezner
Journal:  J Neurooncol       Date:  2013-06-28       Impact factor: 4.130

Review 7.  The future of targeted therapies for brain metastases.

Authors:  Anna S Berghoff; Matthias Preusser
Journal:  Future Oncol       Date:  2015       Impact factor: 3.404

8.  Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial.

Authors:  Eric L Chang; Jeffrey S Wefel; Kenneth R Hess; Pamela K Allen; Frederick F Lang; David G Kornguth; Rebecca B Arbuckle; J Michael Swint; Almon S Shiu; Moshe H Maor; Christina A Meyers
Journal:  Lancet Oncol       Date:  2009-10-02       Impact factor: 41.316

Review 9.  Targeted Therapies for Melanoma Brain Metastases.

Authors:  Anna S Berghoff; Matthias Preusser
Journal:  Curr Treat Options Neurol       Date:  2017-04       Impact factor: 3.598

Review 10.  The role of retreatment in the management of recurrent/progressive brain metastases: a systematic review and evidence-based clinical practice guideline.

Authors:  Mario Ammirati; Charles S Cobbs; Mark E Linskey; Nina A Paleologos; Timothy C Ryken; Stuart H Burri; Anthony L Asher; Jay S Loeffler; Paula D Robinson; David W Andrews; Laurie E Gaspar; Douglas Kondziolka; Michael McDermott; Minesh P Mehta; Tom Mikkelsen; Jeffrey J Olson; Roy A Patchell; Steven N Kalkanis
Journal:  J Neurooncol       Date:  2009-12-03       Impact factor: 4.130

View more
  4 in total

1.  CyberKnife Radiosurgery in Recurrent Brain Metastases: Do the Benefits Outweigh the Risks?

Authors:  Romagna Alexander; Christoph Schwartz; Barbara Ladisich; Wolfgang Hitzl; Sarah-Charlotta Heidorn; Peter A Winkler; Alexander Muacevic
Journal:  Cureus       Date:  2018-12-17

2.  Risk factors for in-brain local progression in elderly patients after resection of cerebral metastases.

Authors:  Christopher Munoz-Bendix; Marion Rapp; Hendrik-Jan Mijderwijk; Christiane von Sass; Maxine Dibué-Adjei; Jan Frederick Cornelius; Hans-Jakob Steiger; Bernd Turowski; Michael Sabel; Marcel A Kamp
Journal:  Sci Rep       Date:  2019-05-15       Impact factor: 4.379

3.  Neurosurgical resection for locally recurrent brain metastasis.

Authors:  Alexander F C Hulsbergen; Abdullah M Abunimer; Fidelia Ida; Vasileios K Kavouridis; Logan D Cho; Ishaan A Tewarie; Rania A Mekary; Philippe Schucht; John G Phillips; Joost J C Verhoeff; Marike L D Broekman; Timothy R Smith
Journal:  Neuro Oncol       Date:  2021-12-01       Impact factor: 13.029

Review 4.  The Management of Brain Metastases-Systematic Review of Neurosurgical Aspects.

Authors:  Martin A Proescholdt; Petra Schödel; Christian Doenitz; Tobias Pukrop; Julius Höhne; Nils Ole Schmidt; Karl-Michael Schebesch
Journal:  Cancers (Basel)       Date:  2021-03-31       Impact factor: 6.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.